Systematic analysis of the role of SLC52A2 in multiple human cancers
Abstract Background: In humans, riboflavin must be obtained through intestinal absorption because it cannot be synthesized by the body. SLC52A2…
Hepatocellular carcinoma
Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma
Abstract Family with sequence similarity 49, member B (FAM49B) is highly expressed in many tumors, its role in malignant tumors…
Analysis of the role of Ly-1 antibody reactive in different cancer types
Abstract LYAR (Ly-1 antibody reactive) is a transcription factor with a specific DNA-binding domain, which plays a key role in…
A Novel Prognostic Biomarker LPAR6 in Hepatocellular Carcinoma via Associating with Immune Infiltrates
Abstract Background and Aims: LPAR6 is the most recently determined G protein-coupled receptor of lysophosphatidic acid, and hardly any study…
Pan-cancer analysis and single-cell analysis revealed the role of ABCC5 transporter in hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer. Many patients with hepatocellular carcinoma are diagnosed at…
Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
Abstract Background: Xanthine dehydrogenase (XDH) is a critical enzyme involved in the oxidative metabolism of purines, pterin and aldehydes and…
PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma
Abstract Background: Protein phosphatase magnesium-dependent 1 delta (PPM1D), also referred to as wild-type p53-induced phosphatase 1 (Wip1) or protein phosphatase…
Pan-cancer analysis of the oncogenic role of discs large homolog associated protein 5 (DLGAP5) in human tumors
Abstract Background: In recent years, there have been many studies on the relationship between DLGAP5 and different types of cancers,…
Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
Abstract Background: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide. PAFAH1B3 plays an important role on…
A Novel Mechanism of Cannabidiol in Suppressing Hepatocellular Carcinoma by Inducing GSDME Dependent Pyroptosis
Abstract Cannabidiol (CBD), a phytochemical derived from Cannabis sativa L., has been demonstrated to exhibit promising anti-tumor properties in multiple…